Taiwan's Biannual Price Cuts Has Companies Seeing Red
This article was originally published in PharmAsia News
Executive SummaryHONG KONG - Taiwan's government plans to carry forward with a biannual round of cuts to drug prices despite intense opposition from the pharmaceutical industry
You may also be interested in...
Although Taiwan’s most recent cuts will have less impact than last go around, industry will still feel the pinch.
Companies threaten to pull drugs from the market if price cuts go through, but government pledges to move forward.